The Current Ratio as of November 2024 (TTM) for ARCA biopharma, Inc. (ABIO) is 26.61

According to ARCA biopharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 26.61. This represents a change of -28.10% compared to the average of 37.01 of the last 4 quarters.

ARCA biopharma, Inc. (ABIO) Historical Current Ratio (quarterly & annually)

How has ABIO Current Ratio performed in the past?

The mean historical Current Ratio of ARCA biopharma, Inc. over the last ten years is 19.62. The current 26.61 Current Ratio has changed 13.46% with respect to the historical average. Over the past ten years (40 quarters), ABIO's Current Ratio was at its highest in in the December 2023 quarter at 59.01. The Current Ratio was at its lowest in in the December 2017 quarter at 5.94.

ARCA biopharma, Inc. (ABIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ARCA biopharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ARCA biopharma, Inc. (ABIO) Average Current Ratio

How has ABIO Current Ratio performed in the past?

The current Current Ratio of ARCA biopharma, Inc. (ABIO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

ARCA biopharma, Inc. (ABIO) Current Ratio vs. Peers

How is ABIO’s Current Ratio compared to its peers?

ARCA biopharma, Inc.’s Current Ratio is greater than Aerovate Therapeutics, Inc. (6.51), greater than Adagene Inc. (2.50), greater than Acrivon Therapeutics, Inc. Common Stock (16.16), greater than Rezolute, Inc. (13.39), greater than AN2 Therapeutics, Inc. (10.61), greater than Indaptus Therapeutics, Inc. (3.88), greater than Tempest Therapeutics, Inc. (2.17), greater than Comera Life Sciences Holdings, Inc. (0.90), greater than Forte Biosciences, Inc. (2.82), greater than ZIVO Bioscience, Inc. (0.17), greater than RenovoRx, Inc. (4.39), greater than Pasithea Therapeutics Corp. (6.20), greater than Quoin Pharmaceuticals, Ltd. (3.35), greater than Sio Gene Therapies Inc. (21.97), greater than Magenta Therapeutics, Inc. (14.64), less than TRACON Pharmaceuticals, Inc. (0), greater than CytomX Therapeutics, Inc. (0.66), greater than Spero Therapeutics, Inc. (1.00), greater than Neoleukin Therapeutics, Inc. (2.68), greater than Instil Bio, Inc. (15.33), greater than NextCure, Inc. (15.06), greater than null (8.35),

Build a custom stock screener for ARCA biopharma, Inc. (ABIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARCA biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ARCA biopharma, Inc. (ABIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ARCA biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.